MarketBeat cites USD 2.19 target for eHealth stock

Published on 10/20/2026 at 20:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MarketBeat lists a USD 2.19 target from three reports. eHealth stock costs EUR 0.52 at Lang & Schwarz on October 20, 2026 during after-hours trading.

Target and earnings date

MarketBeat lists a USD 2.19 consensus target based on three research reports on October 19, 2026.
eHealth reported USD 33.57 million in second-quarter 2026 revenue and a USD 23.60 million net loss.
eHealth stock costs EUR 0.52 at Lang & Schwarz on October 20, 2026 at 7:59 p.m. CEST.
eHealth is estimated to report third-quarter 2026 results on November 4, 2026.

EHTH, US28238P1093, Illustration mit AI erstellt.

eHealth, Inc. (ISIN US28238P1093) has a USD 2.19 consensus target based on three research reports, according to MarketBeat on October 19, 2026. That target stands 277.59 percent above the USD 0.58 Nasdaq price observed on October 20, 2026 at 2:01 p.m. ET. At Lang & Schwarz, the stock was trading at EUR 0.52 on October 20, 2026 at 7:59 p.m. CEST.

Analyst target meets weak results

The target sits against a difficult second-quarter operating picture. eHealth reported USD 33.57 million in second-quarter 2026 revenue, down 45.00 percent from the prior-year quarter, while its net loss widened to USD 23.60 million from USD 17.40 million, Becker's Payer Issues reported on October 20, 2026.

The revenue decline gives the USD 2.19 target a demanding operating backdrop. MarketBeat lists a consensus rating of Reduce and says the target is based on three research reports, while the same page shows a USD 18.10 million market capitalization as of October 19, 2026.

Nasdaq listing faces a compliance test

eHealth said in an October 16, 2026 SEC filing that it had until April 12, 2027, to regain Nasdaq compliance after its shares closed below the USD 1 minimum bid price for 30 consecutive business days, according to Becker's Payer Issues. The company may seek approval for a reverse stock split if other options do not restore compliance.

November 4 is the next date

MarketBeat estimates that eHealth will report third-quarter 2026 results on November 4, 2026, before the Nasdaq opens. Its page lists consensus revenue of USD 26.43 million and consensus earnings per share of minus USD 1.09 for that quarter, compared with reported second-quarter earnings per share of minus USD 1.18, MarketBeat reported on October 19, 2026.

Price remains near the yearly low

On Nasdaq, eHealth was at USD 0.58 on October 20, 2026 at 2:01 p.m. ET. Its 52-week range was USD 0.55 to USD 5.89, and its market capitalization was USD 18.40 million on the same date.

For investors, the next reporting date and the Nasdaq compliance timetable frame the valuation. The company must pair a recovery in revenue with a share price above the USD 1 threshold for the listing issue to recede.

Euro quote after the Xetra close

The stock was trading at EUR 0.52 at Lang & Schwarz on October 20, 2026 at 7:59 p.m. CEST. The real-time quote of eHealth stock is updated continuously.